Among them the fucosylated fraction of AFP, proteoglycans such as glypican 3 and versican, DCP and PIVKA II have been principally investigated for early-stage HCC detection, treatment response monitoring and tumor prognosis evaluation [11,17,18]. Here, AFP is linked to neoplasm.